Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:94
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 82 条
[61]  
PETERS R, 2007, J THROMB HAEMOST S2, V5
[62]   C-reactive protein levels and outcomes after statin therapy [J].
Ridker, PM ;
Cannon, CP ;
Morrow, D ;
Rifai, N ;
Rose, LM ;
McCabe, CH ;
Pfeffer, MA ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :20-28
[63]   Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with Non-ST-segment-elevation acute coronary syndromes [J].
Roffi, M ;
Chew, DP ;
Mukherjee, D ;
Bhatt, DL ;
White, JA ;
Heeschen, C ;
Hamm, CW ;
Moliterno, DJ ;
Califf, RA ;
White, HD ;
Kleiman, NS ;
Theroux, P ;
Topol, EJ .
CIRCULATION, 2001, 104 (23) :2767-2771
[64]   Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction [J].
Sabatine, Marc S. ;
Morrow, David A. ;
Higgins, Luke J. ;
MacGillivray, Catherine ;
Guo, Wei ;
Bode, Christophe ;
Rifai, Nader ;
Cannon, Christopher P. ;
Gerszten, Robert E. ;
Lee, Richard T. .
CIRCULATION, 2008, 117 (15) :1936-1944
[65]   Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 [J].
Sabatine, Marc S. ;
Morrow, David A. ;
de Lemos, James A. ;
Jarolim, Petr ;
Braunwald, Eugene .
EUROPEAN HEART JOURNAL, 2009, 30 (02) :162-169
[66]   Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes - Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide [J].
Sabatine, MS ;
Morrow, DA ;
de Lemos, JA ;
Gibson, CM ;
Murphy, SA ;
Rifai, N ;
McCabe, C ;
Antman, EM ;
Cannon, CP ;
Braunwald, E .
CIRCULATION, 2002, 105 (15) :1760-1763
[67]   Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction [J].
Schröder, K ;
Wegscheider, K ;
Zeymer, U ;
Tebbe, U ;
Schröder, R .
LANCET, 2001, 358 (9292) :1479-1486
[68]   Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome Observations From the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) Trial [J].
Scirica, Benjamin M. ;
Morrow, David A. ;
Budaj, Andrzej ;
Dalby, Anthony J. ;
Mohanavelu, Satishkumar ;
Aroesty, Julian ;
Hedgepeth, Chester M. ;
Stone, Peter H. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (16) :1411-1421
[69]   Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups [J].
Shaw, LJ ;
Peterson, ED ;
Shaw, LK ;
Kesler, KL ;
DeLong, ER ;
Harrell, FE ;
Muhlbaier, LH ;
Mark, DB .
CIRCULATION, 1998, 98 (16) :1622-1630
[70]   One-year cardiovascular event rates in outpatients with atherothrombosis [J].
Steg, Ph. Gabriel ;
Bhatt, Deepak L. ;
Wilson, Peter W. F. ;
D'Agostino, Ralph, Sr. ;
Ohman, E. Magnus ;
Roether, Joachim ;
Liau, Chiau-Suong ;
Hirsch, Alan T. ;
Mas, Jean-Louis ;
Ikeda, Yasuo ;
Pencina, Michael J. ;
Goto, Shinya .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (11) :1197-1206